Kfar-Sava, Israel Clinical Trials

A listing of Kfar-Sava, Israel clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

This study will assess the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of escalating doses of quavonlimab when used in combination with pembrolizumab in participants with advanced solid tumors.

Sheba Medical Center - Cancer Center ( Site 0002)
 (9.0 away) Contact site
  • 742 views
  • 12 Jun, 2021
  • +52 other locations
Evaluate the Safety Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. The pandemic emerged from Wuhan Province in China in December 2019 and was declared by the WHO Director-General a Public Health Emergency of International Concern on 30 January 2020. In this study, a vaccine developed by IIBR for SARS-CoV-2 virus will …

Rabin MC
 (6.6 away) Contact site
  • 0 views
  • 03 May, 2021
  • +7 other locations
A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors

The purpose of this first-in-human (FIH) study of BLZ945 given as a single agent or in combination with PDR001 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of BLZ945, administered orally, as a single agent or in combination with PDR001, administered intravenously (i.v.) in adult patients …

Novartis Investigative Site
 (9.7 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • +17 other locations
T-Cell Vaccination in Multiple Sclerosis (MS)

The purpose of this study is to evaluate the safety of T-cell vaccination in MS patients.

MRI
Multiple Sclerosis Center
 (9.0 away) Contact site
  • 13 views
  • 07 Nov, 2020
  • 1 location
Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

cannabis dependence
cannabis use
addiction
Shalvata Mental Health Center
 (2.4 away) Contact site
  • 20 views
  • 07 Nov, 2020
  • 1 location
The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.

Non-suicidal self-injuries (NSSI) is a deliberate harm a person causes directly to their body, resulting in structural or functional damage, without suicidal ideation. This behavior is related to unbearable internal stress, thoughts, or mental pain, which NSSI assists in dismantling. To date, there is no generally approved therapy that assists …

Psychiatric Service, Tel-Aviv Sourasky Medical Center
 (9.7 away) Contact site
  • 1 views
  • 24 Jan, 2021
  • 1 location
Safety Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT) for the Treatment of Moderate to Severe COVID-19 Patients.

This is a phase I/II study with Amorphous Calcium Carbonate (ACC) administered sublingual and in Inhalation concomitantly with BAT (Best Available Care) as Compared to Placebo and BAT for the treatment of Moderate to Severe COVID-19 patients. The purpose of this study is to assess the Safety, Tolerability and Efficacy …

Tel-Aviv Sourasky MC
 (9.7 away) Contact site
  • 0 views
  • 31 May, 2021
  • +2 other locations
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

immunosuppression
cell transplantation
ibrutinib
Schneider Children's Medical Center in Israel
 (6.6 away) Contact site
  • 47 views
  • 24 Jan, 2021
  • +49 other locations
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

This study will evaluate the safety and efficacy of favezelimab in combination with pembrolizumab (MK-3475) in participants with hematological malignancies: classical Hodgkin lymphoma (cHL) diffuse large B-cell lymphoma (DLBCL) indolent non-Hodgkin lymphoma (iNHL) The study will have 2 phases: a safety lead-in and an efficacy expansion phase. The recommended Phase …

b-cell lymphoma
large b-cell lymphoma
diffuse large b-cell lymphoma
classical hodgkin lymphoma
mk-3475
Chaim Sheba Medical Center. ( Site 0380)
 (9.0 away) Contact site
  • 45 views
  • 03 Jun, 2021
  • +24 other locations
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to: a) establish the recommended phase 2 dose (RP2D) and to evaluate the antitumor activity and safety of niraparib combination therapies (Combinations 1 and 2) and b) to determine the relative bioavailability of niraparib and abiraterone acetate (AA) in combination (Combination 3) in participants …

Rabin Medical Center
 (6.6 away) Contact site
  • 506 views
  • 31 May, 2021
  • +83 other locations